National Knowledge-Driven Management of Obstructive Sleep Apnea—The Swedish Approach

Abstract

Introduction: This paper describes the development of “Swedish Guidelines for OSA treatment” and the underlying managed care process. The Apnea Hypopnea Index (AHI) is traditionally used as a single parameter for obstructive sleep apnea (OSA) severity classification, although poorly associated with symptomatology and outcome. We instead implement a novel matrix for shared treatment decisions based on available evidence. Methods: A national expert group including medical and dental specialists, nurses, and patient representatives developed the knowledge-driven management model. A Delphi round was performed amongst experts from all Swedish regions (N = 24). Evidence reflecting treatment effects was extracted from systematic reviews, meta-analyses, and randomized clinical trials. Results: The treatment decision in the process includes a matrix with five categories from a “very weak”” to “very strong” indication to treat, and it includes factors with potential influence on outcome, including (A) OSA-related symptoms, (B) cardiometabolic comorbidities, (C) frequency of respiratory events, and (D) age. OSA-related symptoms indicate a strong incitement to treat, whereas the absence of symptoms, age above 65 years, and no or well-controlled comorbidities indicate a weak treatment indication, irrespective of AHI. Conclusions: The novel treatment matrix is based on the effects of treatments rather than the actual frequency of respiratory events during sleep. A nationwide implementation of this matrix is ongoing, and the outcome is monitored in a prospective evaluation by means of the Swedish Sleep Apnea Registry (SESAR).

Views on oral health determinants as described by persons with continuous positive airway pressure-treated obstructive sleep apnoea: a qualitative study

“…In the Swedish sleep apnea registry, 34.2% are female and the mean age for females and males are 57 (± 14) years and 54 (± 14) years, respectively. During 2020–21, 50.6% of the patients were recommended CPAP treatment [ 36 ].…”

Novel Technologies in the Diagnosis and Management of Sleep-disordered Breathing

“…Better understanding of patient phenotypes will allow specific characteristics to be linked to treatment outcomes . The variety of accurate data obtained from new connected devices could be used to inform both diagnostics and clinical decision making based on sleep-related breathing parameters, age, symptoms and risks (Hajipour et al, 2023), and in accordance with current clinical recommendations and guidelines Grote et al, 2023). The new capabilities provided by new technologies and innovations bring new capabilities, such as use of the same device to diagnose sleep apnea and then monitor therapy compliance and efficacy.…”

A new approach to streamline obstructive sleep apnea therapy access using peripheral arterial tone-based home sleep test devices

“…Better understanding of patient phenotypes will allow specific characteristics to be linked to treatment outcomes (Mazzotti et al, 2019). The variety of accurate data obtained from new connected devices could be used to inform both diagnostics and clinical decision making based on sleep-related breathing parameters, age, symptoms and risks (Hajipour et al, 2023), and in accordance with current clinical recommendations and guidelines (Patil et al, 2019;Randerath et al, 2021;Grote et al, 2023). The new capabilities provided by new technologies and innovations bring new capabilities, such as use of the same device to diagnose sleep apnea and then monitor therapy compliance and efficacy.…”